Botond Lakatos
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 16
- SARS-CoV-2 and COVID-19 Research 6
- HIV/AIDS Research and Interventions 5
- HIV/AIDS drug development and treatment 4
-
- HIV Research and Treatment 5
-
- Long-Term Effects of COVID-19 11
-
- Pneumocystis jirovecii pneumonia detection and treatment 5
-
- HIV-related health complications and treatments 5
Botond Lakatos
46 papers receiving 262 citations
Peers
Comparison fields: 5 of 76
- Applied Microbiology and Biotechnology 17
- Infectious Diseases 146
- Virology 22
- Neurology 46
- Internal Medicine 11
Countries citing papers authored by Botond Lakatos
This map shows the geographic impact of Botond Lakatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Botond Lakatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Botond Lakatos more than expected).
Fields of papers citing papers by Botond Lakatos
This network shows the impact of papers produced by Botond Lakatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Botond Lakatos. The network helps show where Botond Lakatos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Botond Lakatos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 19 | |
| 15 | Citokinellenes terápia az új típusú koronavírus okozta megbetegedés (COVID–19) kezelésében – tocilizumab elsőként való alkalmazása egy hazai infektológiai osztályon (A COVID–19-pandémia orvosszakmai kérdései) | 2020 | 6 |
| 16 | 2020 | 15 | |
| 17 | 2015 | 11 | |
| 18 | [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary]. | 2014 | 3 |
| 19 | 2014 | 4 | |
| 20 | 2014 | 23 |
About Botond Lakatos
Botond Lakatos is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Virology, having authored 53 papers that have together received 266 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (11 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), HIV-related health complications and treatments (5 papers), HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (17 citations), Infectious Diseases (146 citations) and Virology (22 citations). Botond Lakatos has collaborated with scholars based in Hungary, Romania and Poland. Frequent co-authors include István Vályi‐Nagy, János Szlávik, Manuel Battegay, Bálint Gergely Szabó, Andreas F. Widmer, Reno Frei, Luigia Elzi, Ilona Bobek, Marcel Stoeckle and Catia Marzolini. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.